News

April 30, 2020 – Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for Multiple Sclerosis

View full release as a pdf here:

 

---

April 21, 2020 – Banner Life Sciences Receives Favorable Appellate Court Decision in Biogen Patent Infringement Dispute

View full release as a pdf here:

 

---

January 09, 2020 – Banner Life Sciences Receives Favorable Ruling Against Biogen in Patent Infringement Challenge

View full release as a pdf here:

 

---

July 23, 2019 – Banner Life Sciences Announces First Subject Enrolled in Randomized, Double-Blind Head-to-Head Study of Bafiertam and Tecfidera for Comparative Assessment of GI Tolerability

View full release as a pdf here:

 

---

January 02, 2019 – Banner Receives FDA Tentative Approval for BAFIERTAM for the Treatment of Relapsing Forms of Multiple Sclerosis

View full release as a pdf here:

 

---

Events

Plan to see us in San Francisco – we'll be in town the week of the

JP Morgan Healthcare Conference
San Francisco, CA
Monday through Thursday, January 13–16, 2020